Author(s)

Manoahasina Ranaliarinosy Rabarison¹, Lalaina Nomenjanahary¹, Nantenaina Soa Randrianjafisamindrakotroka²

¹Department of Pathology, Joseph Ravoahangy Andrianavalona University Hospital, Antananarivo, Madagascar.
²Chairman at the Department of Pathology, Medical School of Antananarivo, Antananarivo, Madagascar.

Chronic gastritis is a persistent inflammation of the gastric mucosa. The Sydney System is the most widely used classification of this disease but it does not allow a ranking of patients according to the evolutionary potential of the disease, unlike the classifications: “Operative Link On Gastritis Assessment” (OLGA) and “Operative Link on Gastritis Intestinal Metaplasia Assessment” (OLGIM). Our goals are to apply and evaluate the three classifications: the Sydney System, OLGA and OLGIM and to draw possible correlations. This is a retrospective, descriptive, single-center study performed on all cases of chronic gastritis, diagnosed at the laboratory of Pathological Anatomy Unit of Joseph Ravoahangy Andrianavalona University Hospital from January 1, 2013 to December 31, 2017. A review and application of the three main classification systems was performed on each case. We included 298 cases. The mean age was 50.85 years. The sex ratio was 1.48. The high-risk stages according to the “Operative Link On Gastritis Assessment” (OLGA) system and the “Operative Link on Gastritis Intestinal Metaplasia Assessment” (OLGIM) system were 0.67% and 2.68%, respectively. We observed a correlation between the two systems with discordance of 5%. The use of the two new systems allows the assessment of the progressive potential of gastritis in patients at risk of developing gastric cancer. For optimal effectiveness of both classifications, biopsies should be performed according to the Sydney System recommendations.

Gastritis, Sydney System, OLGA, OLGIM

Rabarison, M. , Nomenjanahary, L. and Randrianjafisamindrakotroka, N. (2022) Evaluation of OLGA and OLGIM Systems in Madagascar, a Country with Low Economic Resources. Open Journal of Pathology, 12, 130-139. doi: 10.4236/ojpathology.2022.124015.